With several thousand clinical trials currently running in Scandinavia, Nordic biotech and pharma companies, CROs and research institutions are increasingly extending their reach into other geographic regions. In this candid interview, Maria Ohlander, Head of Clinical Development at Karo Bio, shares valuable experiences of the multi-partner approach Karo Bio took to develop compounds with an Indian partner and 3 other CROs, and why better integration and strategic partnerships are needed to ensure the quality and quantity of trials.
|
|
Have Your Say Rate this feature and give us your feedback in the comments section below |